PIF Communications Nov 12, 2020 2 min Keros Therapeutics Announces Pricing of Public Offering of Common Stock LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
PIF Communications Oct 1, 2020 3 min BIAL Goes Global w/ New US Research Center and Acquisition of Promising Parkinson's Disease Program BIAL Biotech to be based in Cambridge, Massachusetts and will be a Research Center of Excellence dedicated to genetically-defined...
PIF Communications Jun 8, 2020 2 min 3 months after its B round, Akouos files an IPO to the tune of $100M Boston-based hearing loss gene therapy biotech Akouos is gunning for a $100 million IPO amid a near invulnerable market for...
PIF Communications Apr 27, 2020 2 min Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and D Affinia Therapeutics’ proprietary AAV vector technology to be used in Vertex’s genetic therapy efforts with focus on Duchenne muscular...
PIF Communications Jun 10, 2019 3 min Merck to Acquire Tilos Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ